You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
12 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it is donating more than 2,000 vials of remdesivir to the Republic of Uganda to support response efforts to the Ebola Bundibugyo virus disease (BVD) o...
12 June 2026 - Airiver Medical, a clinical stage company developing technologies to help patients with certain respiratory tract conditions, announced on Thursday the successful treatment of the first patient with chronic rhinosinusitis (CRS) in its ...
12 June 2026 - Commercial-stage biopharmaceutical company Precigen Inc (Nasdaq:PGEN) and the Recurrent Respiratory Papillomatosis Foundation (RRPF) announced on Thursday their continued collaboration in recognition of the third annual International R...
11 June 2026 - Precision oncology company Guardant Health Inc (Nasdaq:GH) announced on Thursday that the US Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic for Boehringer Ingelheim's HERNEXEOS (zongertin...
11 June 2026 - Taiwan-based biopharmaceutical company PharmaEssentia Corporation (TWSE:6446) announced on Thursday the acquisition of Canadian specialty pharmaceutical company FORUS Therapeutics Inc for USD36.5m, advancing its North American commerci...